EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 31 (2024) Parasite, 31 (2024) 68 References
Open Access
Review
Issue
Parasite
Volume 31, 2024
Article Number 68
Number of page(s) 16
DOI https://doi.org/10.1051/parasite/2024067
Published online 31 October 2024
  1. Anonymous. 2019. Immunotherapies for autoimmune diseases. Nature Biomedical Engineering, 3(4), 247. [CrossRef] [PubMed] [Google Scholar]
  2. Acharya S, Da’dara AA, Skelly PJ. 2022. Schistosome immunomodulators. PLoS Pathogens, 17(12), e1010064. [Google Scholar]
  3. Al-Naseri A, Al-Absi S, El Ridi R, Mahana N. 2021. A comprehensive and critical overview of schistosomiasis vaccine candidates. Journal of Parasitic Diseases, 45(2), 557–580. [CrossRef] [PubMed] [Google Scholar]
  4. Alfadul H, Sabico S, Al-Daghri NM. 2022. The role of interleukin-1β in type 2 diabetes mellitus: a systematic review and meta-analysis. Frontiers in Endocrinology, 13, 901616. [CrossRef] [PubMed] [Google Scholar]
  5. Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. 2015. Autoimmune thyroid disorders. Autoimmunity Reviews, 14(2), 174–180. [CrossRef] [PubMed] [Google Scholar]
  6. Błach J, Wojas-Krawczyk K, Nicoś M, Krawczyk P. 2021. Failure of immunotherapy-the molecular and immunological origin of immunotherapy resistance in lung cancer. International Journal of Molecular Sciences, 22(16), 9030. [CrossRef] [PubMed] [Google Scholar]
  7. Blagov AV, Summerhill VI, Sukhorukov VN, Popov MA, Grechko AV, Orekhov AN. 2023. Type 1 diabetes mellitus: inflammation, mitophagy, and mitochondrial function. Mitochondrion, 72, 11–21. [CrossRef] [PubMed] [Google Scholar]
  8. Brito CF, Caldas IR, Coura Filho, P, Correa-Oliveira R, Oliveira, SC. 2000. CD4+ T Cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon‐γ and tumour necrosis factor‐α in response to the recombinant 14kda Schistosoma mansoni fatty acid‐binding protein. Scandinavian Journal of Immunology, 51(6), 595–601. [CrossRef] [PubMed] [Google Scholar]
  9. Brito CF, Oliveira GC, Oliveira SC, Street M, Riengrojpitak S, Wilson RA, Simpson AJ, Correa-Oliveira R. 2002. Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm. Brazilian Journal of Medical and Biological Research, 35(3), 377–381. [CrossRef] [PubMed] [Google Scholar]
  10. Burky M, Trembath D, Bookhout C. 2022. Rectal carcinoma arising in a patient with intestinal and hepatic schistosomiasis due to Schistosoma mekongi. IDCases, 27, e01383. [CrossRef] [PubMed] [Google Scholar]
  11. Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q. 2020. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy. Pharmacological Research, 155, 104720. [CrossRef] [PubMed] [Google Scholar]
  12. Cao X, Fu Z, Zhang M, Han Y, Han Q, Lu K, Li H, Zhu C, Hong Y, Lin J. 2016. Excretory/secretory proteome of 14-day schistosomula, Schistosoma japonicum. Journal of Proteomics, 130, 221–230. [CrossRef] [PubMed] [Google Scholar]
  13. Capron M, Béghin L, Leclercq C, Labreuche J, Dendooven A, Standaert A, Delbeke M, Porcherie A, Nachury M, Boruchowicz A, Dupas JL, Fumery M, Paupard T, Catteau S, Deplanque D, Colombel JF, Desreumaux P. 2019. Safety of P28GST, a protein derived from a schistosome helminth parasite, in patients with Crohn’s disease: a pilot study (ACROHNEM). Journal of Clinical Medicine, 9(1), 41. [CrossRef] [PubMed] [Google Scholar]
  14. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, de Melo AL, Caliari MV, Almeida GT, Venancio TM, Verjovski-Almeida S, Oliveira SC. 2008. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Neglected Tropical Diseases, 2(10), e308. [CrossRef] [PubMed] [Google Scholar]
  15. Cardoso LS, Oliveira SC, Goes AM, Oliveira RR, Pacifico LG, Marinho FV, Fonseca CT, Cardoso FC, Carvalho EM, Araujo MI. 2010. Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clinical and Experimental Immunology, 160(2), 266–274. [CrossRef] [PubMed] [Google Scholar]
  16. Carson JP, Robinson MW, Ramm GA, Gobert GN. 2022. Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells. Experimental Parasitology, 236–237, 108255. [CrossRef] [PubMed] [Google Scholar]
  17. Castro-Borges W, Wilson RA. 2022. Schistosome proteomics: updates and clinical implications. Expert Review of Proteomics, 19(4–6), 247–261. [CrossRef] [PubMed] [Google Scholar]
  18. Chandrashekara S. 2012. The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review. Indian Journal of Pharmacology, 44(6), 665–671. [CrossRef] [PubMed] [Google Scholar]
  19. Chinen T, Kannan AK, Levine AG, Fan X, Klein U, Zheng Y, Gasteiger G, Feng Y, Fontenot JD, Rudensky AY. 2016. An essential role for the IL-2 receptor in T(reg) cell function. Nature Immunology, 17(11), 1322–1333. [CrossRef] [PubMed] [Google Scholar]
  20. Cleenewerk L, Garssen J, Hogenkamp A. 2020. Clinical use of Schistosoma mansoni antigens as novel immunotherapies for autoimmune disorders. Frontiers in Immunology, 11, 1821. [CrossRef] [PubMed] [Google Scholar]
  21. Collins JJ, 3rd, Wendt GR, Iyer H, Newmark PA. 2016. Stem cell progeny contribute to the schistosome host-parasite interface. eLife, 5, e12473. [CrossRef] [PubMed] [Google Scholar]
  22. Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G. 2023. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet, 401(10391), 1878–1890. [CrossRef] [PubMed] [Google Scholar]
  23. Cooper AJR, Dholakia S, Holland CV, Friend PJ. 2017. Helminths in organ transplantation. Lancet Infectious Diseases, 17(6), e166–e176. [CrossRef] [Google Scholar]
  24. Cummings RD, Nyame AK. 1999. Schistosome glycoconjugates. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1455(2), 363–374. [CrossRef] [Google Scholar]
  25. Curwen RS, Ashton PD, Sundaralingam S, Wilson RA. 2006. Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry. Molecular & Cellular Proteomics, 5(5), 835–844. [CrossRef] [PubMed] [Google Scholar]
  26. Davies TF, Latif R. 2019. Editorial: TSH receptor and autoimmunity. Frontiers in Endocrinology (Lausanne), 10, 19. [CrossRef] [Google Scholar]
  27. de Melo TT, Mendes MM, Alves CC, Carvalho GB, Fernandes VC, Pimenta DLF, de Moraes Mourão M, Gai F, Kalli M, Coelho A, de Azambuja Ribeiro RIM, Falcone FH, Pereira RADS, Fonseca CT. 2019. The Schistosoma mansoni cyclophilin A epitope 107–121 induces a protective immune response against schistosomiasis. Molecular Immunology, 111, 172–181. [CrossRef] [PubMed] [Google Scholar]
  28. de Oliveira Fraga LA, Lamb EW, Moreno EC, Chatterjee M, Dvořák J, Delcroix M, Sajid M, Caffrey CR, Davies SJ. 2010. Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection. BMC Immunology, 11, 56. [CrossRef] [PubMed] [Google Scholar]
  29. Dendrou CA, Fugger L, Friese MA. 2015. Immunopathology of multiple sclerosis. Nature Reviews Immunology, 15(9), 545–558. [CrossRef] [PubMed] [Google Scholar]
  30. Dharmage SC, Perret JL, Custovic A. 2019. Epidemiology of asthma in children and adults. Frontiers in Pediatrics, 7, 246. [CrossRef] [PubMed] [Google Scholar]
  31. Ding L, Shu Z, Hao J, Luo X, Ye X, Zhu W, Duan W, Chen Z. 2022. Schixator, a new FXa inhibitor from Schistosoma japonicum with antithrombotic effect and low bleeding risk. Biochemical and Biophysical Research Communications, 603, 138–143. [CrossRef] [PubMed] [Google Scholar]
  32. Donath MY, Dinarello CA, Mandrup-Poulsen T. 2019. Targeting innate immune mediators in type 1 and type 2 diabetes. Nature Reviews in Immunology, 19(12), 734–746. [CrossRef] [PubMed] [Google Scholar]
  33. Driss V, El Nady M, Delbeke M, Rousseaux C, Dubuquoy C, Sarazin A, Gatault S, Dendooven A, Riveau G, Colombel JF, Desreumaux P, Dubuquoy L, Capron M. 2016. The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils. Mucosal Immunology, 9(2), 322–335. [CrossRef] [PubMed] [Google Scholar]
  34. Eissa MM, Ismail CA, El-Azzouni MZ, Ghazy AA, Hadi MA. 2019. Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer. Investigational New Drugs, 37(1), 47–56. [CrossRef] [PubMed] [Google Scholar]
  35. Eissa MM, Mostafa DK, Ghazy AA, El Azzouni MZ, Boulos LM, Younis LK. 2016. Anti-arthritic activity of Schistosoma mansoni and Trichinella spiralis derived-antigens in adjuvant arthritis in rats: role of FOXP3+ treg cells. PLoS One, 11(11), e0165916. [CrossRef] [PubMed] [Google Scholar]
  36. El-Faham MH, Wheatcroft-Francklow KJ, Price HP, Sayers JR, Doenhoff MJ. 2017. Schistosoma mansoni cercarial elastase (SmCE): differences in immunogenic properties of native and recombinant forms. Parasitology, 144(10), 1356–1364. [CrossRef] [PubMed] [Google Scholar]
  37. Everts B, Hussaarts L, Driessen NN, Meevissen MH, Schramm G, van der Ham AJ, van der Hoeven B, Scholzen T, Burgdorf S, Mohrs M, Pearce EJ, Hokke CH, Haas H, Smits HH, Yazdanbakhsh M. 2012. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. Journal of Experimental Medicine, 209(10), 1753–1767, S1. [CrossRef] [PubMed] [Google Scholar]
  38. Felizatti AP, Zeraik AE, Basso LGM, Kumagai PS, Lopes JLS, Wallace BA, Araujo APU, DeMarco R. 2020. Interactions of amphipathic α-helical MEG proteins from Schistosomamansoni with membranes. Biochimica et Biophysica Acta Biomembranes, 1862(3), 183173. [CrossRef] [PubMed] [Google Scholar]
  39. Floudas A, Cluxton CD, Fahel J, Khan AR, Saunders SP, Amu S, Alcami A, Fallon PG. 2017 .Composition of the Schistosoma mansoni worm secretome: identification of immune modulatory Cyclophilin A. PLoS Neglected Tropical Diseases, 11(10), e0006012. [CrossRef] [PubMed] [Google Scholar]
  40. Foligné B, Plé C, Titécat M, Dendooven A, Pagny A, Daniel C, Singer E, Pottier M, Bertin B, Neut C, Deplanque D, Dubuquoy L, Desreumaux P, Capron M, Standaert A. 2019. Contribution of the gut microbiota in P28GST-mediated anti-inflammatory effects: experimental and clinical insights. Cells, 8(6), 577. [CrossRef] [PubMed] [Google Scholar]
  41. Gan X, Gu J, Ju Z, Lu L. 2022. Diverse roles of immune cells in transplant rejection and immune tolerance. Engineering, 10, 44–56. [CrossRef] [Google Scholar]
  42. Gao X, Mao C, Zheng T, Xu X, Luo X, Zhang S, Liu J, Wang X, Chen X, Dong L. 2023. Schistosoma japonicum-derived peptide SJMHE1 ameliorates allergic symptoms and responses in mice with allergic rhinitis. Frontiers in Cellular and Infection Microbiology, 13, 1143950. [CrossRef] [PubMed] [Google Scholar]
  43. Garbuzenko DV. 2022. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. World Journal of Clinical Cases, 10(12), 3662–3676. [CrossRef] [PubMed] [Google Scholar]
  44. Gomez-Bris R, Saez AHerrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM. 2023. CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease. International Journal of Molecular Sciences, 24(3), 2696. [CrossRef] [PubMed] [Google Scholar]
  45. Green DS, Young HA, Valencia JC. 2017. Current prospects of type II interferon γ signaling and autoimmunity. Journal of Biological Chemistry, 292(34), 13925–13933. [CrossRef] [Google Scholar]
  46. Haeberlein S, Obieglo K, Ozir-Fazalalikhan A, Chayé MAM, Veninga H, van der Vlugt L, Voskamp A, Boon L, den Haan JMM, Westerhof LB, Wilbers RHP, Schots A, Schramm G, Hokke CH, Smits HH. 2017. Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells. PLoS Pathogens, 13(7), e1006539. [CrossRef] [PubMed] [Google Scholar]
  47. Hambrook JR, Hanington PC. 2020. Immune evasion strategies of schistosomes. Frontiers in Immunology, 11, 624178. [Google Scholar]
  48. Hams E, Bermingham R, Wurlod FA, Hogan AE, O’Shea D, Preston RJ, Rodewald HR, McKenzie AN, Fallon PG. 2016. The helminth T2 RNase ω1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism. FASEB journal, 30(2), 824–835. [CrossRef] [PubMed] [Google Scholar]
  49. Hasby EA, Hasby Saad MA, Shohieb Z, El Noby K. 2015. FoxP3+ T regulatory cells and immunomodulation after Schistosoma mansoni egg antigen immunization in experimental model of inflammatory bowel disease. Cellular Immunology, 295(1), 67–76. [CrossRef] [PubMed] [Google Scholar]
  50. Hiam-Galvez KJ, Allen BM, Spitzer MH. 2021. Systemic immunity in cancer. Nature Reviews Cancer, 21(6), 345–359. [CrossRef] [PubMed] [Google Scholar]
  51. Hou X, Zhu F, Zheng W, Jacques ML, Huang J, Guan F, Lei J. 2022. Protective effect of Schistosoma japonicum eggs on TNBS-induced colitis is associated with regulating Treg/Th17 balance and reprogramming glycolipid metabolism in mice. Frontiers in Cellular and Infection Microbiology, 12, 1028899. [CrossRef] [PubMed] [Google Scholar]
  52. Huang DL, He YR, Liu YJ, He HY, Gu ZY, Liu YM, Liu WJ, Luo Z, Ju MJ. 2023. The immunomodulation role of Th17 and Treg in renal transplantation. Frontiers in Immunology, 14, 1113560. [CrossRef] [PubMed] [Google Scholar]
  53. Hung SI, Preclaro IAC, Chung WH, Wang CW. 2022. Immediate hypersensitivity reactions induced by COVID-19 vaccines: current trends, potential mechanisms and prevention strategies. Biomedicines 10(6), 1260. [CrossRef] [PubMed] [Google Scholar]
  54. Hussaarts L, García-Tardón N, van Beek L, Heemskerk MM, Haeberlein S, van der Zon GC, Ozir-Fazalalikhan A, Berbée JF, Willems van Dijk K, van Harmelen V, Yazdanbakhsh M, Guigas B. 2015. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB Journal, 29(7), 3027–3039. [CrossRef] [PubMed] [Google Scholar]
  55. Ittiprasert W, Mann VH, Karinshak SE, Coghlan A, Rinaldi G, Sankaranarayanan G, Chaidee A, Tanno T, Kumkhaek C, Prangtaworn P, Mentink-Kane MM, Cochran CJ, Driguez P, Holroyd N, Tracey A, Rodpai R, Everts B, Hokke CH, Hoffmann KF, Berriman M, Brindley PJ. 2019. Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni. eLife, 8, e41337. [CrossRef] [PubMed] [Google Scholar]
  56. Ivashkiv LB. 2018. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nature Reviews Immunology, 18(9), 545–558. [CrossRef] [PubMed] [Google Scholar]
  57. Jang S, Kwon EJ, Lee JJ. 2022. Rheumatoid arthritis: pathogenic roles of diverse immune cells. International Journal of Molecular Sciences, 23(2), 905. [CrossRef] [PubMed] [Google Scholar]
  58. Jenkins SJ, Mountford AP. 2005. Dendritic cells activated with products released by schistosome larvae drive th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infection and Immunity, 73(1), 395–402. [CrossRef] [PubMed] [Google Scholar]
  59. Jiang J, Li J, Zhang Y, Zhou C, Guo C, Zhou Z, Ming Y. 2022. The protective effect of the soluble egg antigen of Schistosoma japonicum in a mouse skin transplantation model. Frontiers in Immunology, 13, 884006. [CrossRef] [PubMed] [Google Scholar]
  60. Jung SM, Kim W-U. 2022. Targeted immunotherapy for autoimmune disease. Immune Network, 22(1), e9. [CrossRef] [PubMed] [Google Scholar]
  61. Kaur I, Schramm G, Everts B, Scholzen T, Kindle Karin B, Beetz C, Montiel-Duarte C, Blindow S, Jones Arwyn T, Haas H, Stolnik S, Heery David M, Falcone Franco H. 2011. Interleukin-4-inducing principle from Schistosoma mansoni eggs contains a functional c-terminal nuclear localization signal necessary for nuclear translocation in mammalian cells but not for its uptake. Infection and Immunity, 79(4), 1779–1788. [CrossRef] [PubMed] [Google Scholar]
  62. Keegan AD, Leonard WJ, Zhu J. 2021. Recent advances in understanding the role of IL-4 signaling. Faculty Reviews, 10, 71. [CrossRef] [PubMed] [Google Scholar]
  63. Khatami A, Bahadory S, Ghorbani S, Saadati H, Zarei M, Soleimani A, Zibaei M. 2021. Two rivals or colleagues in the liver? Hepatit B virus and Schistosoma mansoni co-infections: A systematic review and meta-analysis. Microbial Pathogenesis, 154, 104828. [CrossRef] [PubMed] [Google Scholar]
  64. Klaver EJ, Kuijk LM, Lindhorst TK, Cummings RD, van Die I. 2015. Schistosoma mansoni soluble egg antigens induce expression of the negative regulators SOCS1 and SHP1 in human dendritic cells via interaction with the mannose receptor. PLoS One, 10(4), e0124089. [CrossRef] [PubMed] [Google Scholar]
  65. Knuhr K, Langhans K, Nyenhuis S, Viertmann K, Kildemoes AMO, Doenhoff MJ, Haas H, Schramm G. 2018. Schistosoma mansoni egg-released IPSE/alpha-1 dampens inflammatory cytokine responses via basophil interleukin (IL)-4 and IL-13. Frontiers in Immunology, 9, 2293. [CrossRef] [PubMed] [Google Scholar]
  66. Lam HYP, Huang S-P, Liang T-R, Wu W-J, Cheng P-C, Chang K-C, Peng S-Y. 2022. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni. Parasitology International, 86, 102446. [CrossRef] [PubMed] [Google Scholar]
  67. Lam HYP, Yang TH, Liang TR, Cheng PC, Chang KC, Peng SY. 2021. Heat-killed Propionibacterium acnes augment the protective effect of 28-kDa glutathione S-transferases antigen against Schistosoma mansoni infection. Acta Tropica, 222, 106033. [CrossRef] [PubMed] [Google Scholar]
  68. Li J, Liu H, Jiang J, She X, Niu Y, Ming Y. 2020. The potential role of schistosome-associated factors as therapeutic modulators of the immune system. Infection and Immunity, 88(8), e00754-19. [CrossRef] [PubMed] [Google Scholar]
  69. Lima LM, Cardoso LS, Santos SB, Oliveira RR, Oliveira SC, Goes AM, Loukas A, Araujo MI. 2017. Schistosoma antigens downregulate CXCL9 production by PBMC of HTLV-1-infected individuals. Acta Tropica, 167, 157–162. [CrossRef] [PubMed] [Google Scholar]
  70. Loffek S, Schilling O, Franzke CW. 2011. Series “matrix metalloproteinases in lung health and disease”: biological role of matrix metalloproteinases: a critical balance. European Respiratory Journal, 38(1), 191–208. [CrossRef] [PubMed] [Google Scholar]
  71. Lopes DM, Oliveira SC, Page B, Carvalho LP, Carvalho EM, Cardoso LS. 2018. Schistosoma mansoni rSm29 antigen induces a regulatory phenotype on dendritic cells and lymphocytes from patients with cutaneous leishmaniasis. Frontiers in Immunology, 9, 3122. [Google Scholar]
  72. Lundy SK, Lukacs NW. 2013. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Frontiers in Immunology, 4, 39. [CrossRef] [PubMed] [Google Scholar]
  73. Ma S, Zai J, Han Y, Hong Y, Zhang M, Cao X, Han Q, Lu K, Zhao Z, Lin J, Fu Z. 2017. Characterization of Schistosoma japonicum tetraspanning orphan receptor and its role in binding to complement C2 and immunoprotection against murine schistosomiasis. Parasites & Vectors, 10(1), 288. [CrossRef] [PubMed] [Google Scholar]
  74. Maestas DR, Chung L, Han J, Wang X, Sommerfeld SD, Kelly SH, Moore E, Nguyen HH, Mejías JC, Peña AN, Zhang H, Hooks JST, Chin AF, Andorko JI, Berlinicke CA, Krishnan K, Choi Y, Anderson AE, Mahatme R, Mejia C, Eric M, Woo J, Ganguly S, Zack DJ, Zhao L, Pearce EJ, Housseau F, Pardoll DM, Elisseeff JH. 2023. Helminth egg derivatives as proregenerative immunotherapies. Applied Biological Sciences, 120(8), e2211703120. [Google Scholar]
  75. Marinho Y, Villarreal ES, Aboagye SY, Williams DL, Sun J, Silva CLM, Lutz SE, Oliveira SD. 2023. Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression. Frontiers in Immunology, 14, 1254762. [CrossRef] [PubMed] [Google Scholar]
  76. Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P, Lababidi H, Ledanois O, Mahoub B, Perng D-W, Vazquez JC, Yorgancioglu A. 2022. Type 2 inflammation in asthma and other airway diseases. European Respiratory Journal Open Research, 8(3), 00576–02021. [Google Scholar]
  77. Mathieson W, Wilson RA. 2010. A comparative proteomic study of the undeveloped and developed Schistosoma mansoni egg and its contents: the miracidium, hatch fluid and secretions. International Journal for Parasitology, 40(5), 617–628. [CrossRef] [PubMed] [Google Scholar]
  78. Matucci A, Vultaggio A, Maggi E, Kasujee I. 2018.Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respiratory Research, 19(1), 113. [CrossRef] [PubMed] [Google Scholar]
  79. Mbanefo EC, Agbo CT, Zhao Y, Lamanna OK, Thai KH, Karinshak SE, Khan MA, Fu CL, Odegaard JI, Saltikova IV, Smout MJ, Pennington LF, Nicolls MR, Jardetzky TS, Loukas A, Brindley PJ, Falcone FH, Hsieh MH. 2020. IPSE, an abundant egg-secreted protein of the carcinogenic helminth Schistosoma haematobium, promotes proliferation of bladder cancer cells and angiogenesis. Infectious Agents and Cancer, 15, 63. [CrossRef] [PubMed] [Google Scholar]
  80. McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou X-N. 2018. Schistosomiasis. Nature Reviews Disease Primers, 4(1), 13. [CrossRef] [PubMed] [Google Scholar]
  81. Meng N, Xia M, Lu Y-Q, Wang M, Boini KM, Li P-L, Tang W-X. 2016. Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection. Oncotarget, 7(2639316. [CrossRef] [PubMed] [Google Scholar]
  82. Molehin AJ, Sennoune SR, Zhang W, Rojo JU, Siddiqui AJ, Herrera KA, Johnson L, Sudduth J, May J, Siddiqui AA. 2017. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium. Parasitology Research, 116(11), 3175–3188. [CrossRef] [PubMed] [Google Scholar]
  83. Morais SB, Figueiredo BC, Assis NRG, Alvarenga DM, de Magalhães MTQ, Ferreira RS, Vieira AT, Menezes GB, Oliveira SC. 2018. Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation. PLoS Pathogens, 14(2), e1006870. [CrossRef] [PubMed] [Google Scholar]
  84. Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T. 2021. The role of IL-17 cytokines in psoriasis. ImmunoTargets and Therapy, 10, 409–418. [CrossRef] [Google Scholar]
  85. Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, Manger B, Mackensen A, Schett G. 2021. CD19-targeted CAR T cells in refractory systemic lupus erythematosus. New England Journal of Medicine, 385(6), 567–569. [CrossRef] [PubMed] [Google Scholar]
  86. Mouser EEIM, Pollakis G, Smits HH, Thomas J, Yazdanbakhsh M, de Jong EC, Paxton WA. 2019. Schistosoma mansoni soluble egg antigen (SEA) and recombinant Omega-1 modulate induced CD4+ T-lymphocyte responses and HIV-1 infection in vitro. PLoS Pathogens, 15(9), e1007924. [CrossRef] [PubMed] [Google Scholar]
  87. Mu Y, McManus DP, Hou N, Cai P. 2021. Schistosome infection and schistosome-derived products as modulators for the prevention and alleviation of immunological disorders. Frontiers in Immunology, 12, 619776. [CrossRef] [PubMed] [Google Scholar]
  88. Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B.2004. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves’ hyperthyroidism. Journal of Immunology, 173(3), 2167–2173. [CrossRef] [PubMed] [Google Scholar]
  89. Nakayama Y, Watanabe R, Yamamoto W, Ebina K, Hirano T, Kotani T, Shiba H, Katayama M, Son Y, Amuro H, Onishi A, Jinno S, Hara R, Murakami K, Murata K, Ito H, Tanaka M, Matsuda S, Morinobu A, Hashimoto M. 2024. IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study. Rheumatology , 63(2), 349–357. [CrossRef] [PubMed] [Google Scholar]
  90. Pearce EJ 2005. Priming of the immune response by schistosome eggs. Parasite Immunology, 27(7–8), 265–270. [CrossRef] [PubMed] [Google Scholar]
  91. Peterkova K, Konecny L, Machacek T, Jedlickova L, Winkelmann F, Sombetzki M, Dvorak J. 2024. Winners vs. losers: Schistosoma mansoni intestinal and liver eggs exhibit striking differences in gene expression and immunogenicity, PLoS Pathogens, 20(5), e1012268. [CrossRef] [PubMed] [Google Scholar]
  92. Pila EA, Li H, Hambrook JR, Wu X, Hanington PC. 2017. Schistosomiasis from a snail’s perspective: advances in snail immunity. Trends in Parasitology, 33(11), 845–857. [CrossRef] [PubMed] [Google Scholar]
  93. Porchet E, McNair A, Caron A, Kusnierz JP, Zemzoumi K, Capron A. 2009. Tissue expression of the Schistosoma mansoni 28 kDa glutathione S-transferase. Parasitology, 109(5), 565–572. [Google Scholar]
  94. Portet A, Pinaud S, Tetreau G, Galinier R, Cosseau C, Duval D, Grunau C, Mitta G, Gourbal B. 2017. Integrated multi-omic analyses in Biomphalaria-Schistosoma dialogue reveal the immunobiological significance of FREP-SmPoMuc interaction. Developmental and Comparative Immunology, 75, 16–27. [CrossRef] [PubMed] [Google Scholar]
  95. Qiu S, Fan X, Yang Y, Dong P, Zhou W, Xu Y, Zhou Y, Guo F, Zheng Y, Yang J-Q. 2017. Schistosoma japonicum infection downregulates house dust mite-induced allergic airway inflammation in mice. PLoS One, 12(6), e0179565. [CrossRef] [PubMed] [Google Scholar]
  96. Ranasinghe SL, Fischer K, Gobert GN, McManus DP. 2015. Functional expression of a novel Kunitz type protease inhibitor from the human blood fluke Schistosoma mansoni. Parasit Vectors, 8, 408. [CrossRef] [PubMed] [Google Scholar]
  97. Ren J, Hu L, Yang J, Yang L, Gao F, Lu P, Fan M, Zhu Y, Liu J, Chen L, Gupta S, Yang X, Liu P. 2016. Novel T-cell epitopes on Schistosoma japonicum SjP40 protein and their preventive effect on allergic asthma in mice. European Journal of Immunology, 46(5), 1203–1213. [CrossRef] [PubMed] [Google Scholar]
  98. Rodríguez-Lobato LG, Oliver-Caldés A, Moreno DF, Fernández de Larrea C, Bladé J. 2021. Why immunotherapy fails in multiple myeloma. Frontiers in Oncology, 2(1), 1–42. [Google Scholar]
  99. Roger E, Gourbal B, Grunau C, Pierce RJ, Galinier R, Mitta G. 2008. Expression analysis of highly polymorphic mucin proteins (Sm PoMuc) from the parasite Schistosoma mansoni. Molecular and Biochemical Parasitology, 157(2), 217–227. [CrossRef] [PubMed] [Google Scholar]
  100. Rosenblum MD, Remedios KA, Abbas AK. 2015. Mechanisms of human autoimmunity. Journal of Clinical Investigation, 125(6), 2228–2233. [CrossRef] [PubMed] [Google Scholar]
  101. Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y. 2006. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Cancer Research, 66(8), 4139–4148. [CrossRef] [PubMed] [Google Scholar]
  102. Salim OEH, Hamid HKS, Mekki SO, Suleiman SH, Ibrahim SZ. 2010. Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World Journal of Surgical Oncology, 8(1), 68. [CrossRef] [PubMed] [Google Scholar]
  103. Sanin DE, Mountford AP. 2015. Sm16, a major component of Schistosoma mansoni cercarial excretory/secretory products, prevents macrophage classical activation and delays antigen processing. Parasit Vectors, 8, 1. [CrossRef] [PubMed] [Google Scholar]
  104. Santini-Oliveira M, Machado Pinto P, Santos TD, Vilar MM, Grinsztejn B, Veloso V, Paes-de-Almeida EC, Amaral MAZ, Ramos CR, Marroquin-Quelopana M, Coler R, Reed S, Ciol MA, Savino W, Parra JC, Almeida M, Tendler M. 2022. Development of the Sm14/GLA-SE schistosomiasis vaccine candidate: an open, non-placebo-controlled, standardized-dose immunization phase Ib clinical trial targeting healthy young women. Vaccines (Basel), 10(10), 1724. [CrossRef] [PubMed] [Google Scholar]
  105. Santos LL, Santos J, Gouveia MJ, Bernardo C, Lopes C, Rinaldi G, Brindley PJ, JMCd Costa. 2021. Urogenital schistosomiasis – history, pathogenesis, and bladder cancer. Journal of Clinical Medicine, 10(2), 205. [CrossRef] [PubMed] [Google Scholar]
  106. Sarazin A, Dendooven A, Delbeke M, Gatault S, Pagny A, Standaert A, Rousseaux C, Desreumaux P, Dubuquoy L, Capron M. 2018. Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses. PLoS One, 13(12), e0209681. [CrossRef] [PubMed] [Google Scholar]
  107. Schwartz C, Fallon PG. 2018. Schistosoma “Eggs-Iting” the host: granuloma formation and egg excretion. Frontiers in Immunology, 9, 2492. [CrossRef] [PubMed] [Google Scholar]
  108. Shan W, Zhang W, Xue F, Ma Y, Dong L, Wang T, Zheng Y, Feng D, Chang M, Yuan G, Wang X. 2021. Schistosoma japonicum peptide SJMHE1 inhibits acute and chronic colitis induced by dextran sulfate sodium in mice. Parasit Vectors, 14(1), 455. [CrossRef] [PubMed] [Google Scholar]
  109. Sharaf OF, Ahmed AA, Ibrahim AF, Shariq A, Alkhamiss AS, Alghsham R, Althwab SA, Alghaniam SA, Alhumaydhi FA, Alghamdi R, Alshomar A, Alabdullatif T, Alkhulayfi A, Alghunaim AA, Abdulmonem WA. 2022. Modulation of mice immune responses against Schistosoma mansoni infection with anti-schistosomiasis drugs: Role of interleukin-4 and interferon-gamma. International Journal of Health Sciences (Qassim), 16(2), 3–11. [Google Scholar]
  110. Shiels J, Cwiklinski K, Alvarado R, Thivierge K, Cotton S, Gonzales Santana B, To J, Donnelly S, Taggart CC, Weldon S, Dalton JP. 2020, Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs). PLoS Neglected Tropical Diseases, 14(7), e0008470. [CrossRef] [PubMed] [Google Scholar]
  111. Shousha HI, Abdelaziz AO, Nabeel MM, Omran DA, Abdelmaksoud AH, Elbaz TM, Salah A, Harb STE, Hosny KA, Osman A, Atef M, Gaber A, Zayed NA, Yosry AA, Leithy R. 2022. Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade. Pathogens and Global Health, 116(2), 119–127. [CrossRef] [PubMed] [Google Scholar]
  112. Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie AN, van Rooijen N, Fallon PG. 2007. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism, Journal of Immunology, 178(7), 4557–4566. [CrossRef] [PubMed] [Google Scholar]
  113. Su X, Yu Y, Zhong Y, Giannopoulou EG, Hu X, Liu H, Cross JR, Rätsch G, Rice CM, Ivashkiv LB. 2015. Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation. Nature Immunology, 16(8)838–849. [CrossRef] [PubMed] [Google Scholar]
  114. Tallima H, Abou El Dahab M, Kareem S, Dalton JP, El Ridi R. 2017. Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3. Vaccine, 35(50), 6977–6983. [CrossRef] [PubMed] [Google Scholar]
  115. Tang CL, Yu XH, Li Y, Zhang RH, Xie J, Liu ZM. 2019. Schistosoma japonicum soluble egg antigen protects against type 2 diabetes in lepr (db/db) mice by enhancing regulatory t cells and th2 cytokines. Frontiers Immunology, 10, 1471. [CrossRef] [Google Scholar]
  116. Tang H, Liang YB, Chen ZB, Du LL, Zeng LJ, Wu JG, Yang W, Liang HP, Ma ZF 2017. Soluble egg antigen activates m2 macrophages via the STAT6 and PI3K pathways, and Schistosoma japonicum alternatively activates macrophage polarization to improve the survival rate of septic mice. Journal of Cellular Biochemistry, 118(12), 4230–4239. [CrossRef] [PubMed] [Google Scholar]
  117. Verjee MA. 2019. Schistosomiasis: Still a cause of significant morbidity and mortality. Research and Reports in Tropical Medicine, 10, 153–163. [Google Scholar]
  118. Verreycken J, Baeten P, Broux B. 2022. Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers. Human Vaccines and Immunotherapeutics, 18(7), 2153534. [CrossRef] [PubMed] [Google Scholar]
  119. Vlaminck J, Lagatie O, Dana D, Mekonnen Z, Geldhof P, Levecke B, Stuyver LJ. 2021. Identification of antigenic linear peptides in the soil-transmitted helminth and Schistosoma mansoni proteome. PLoS Neglected Tropical Diseases, 15(4), e0009369. [CrossRef] [PubMed] [Google Scholar]
  120. Wang Q, Lao M, Xu Z, Ding M, Guo S, Li L. 2020. Caveolin‑1 modulates hypertensive vascular remodeling via regulation of the Notch pathway. Molecular Medicine Reports, 22(5), 4320–4328. [PubMed] [Google Scholar]
  121. Wang X, Wang J, Liang Y, Ni H, Shi L, Xu C, Zhou Y, Su Y, Mou X, Chen D, Mao C. 2016. Schistosoma japonicum HSP60-derived peptide SJMHE1 suppresses delayed-type hypersensitivity in a murine model. Parasites & Vectors, 9(1), 147. [CrossRef] [PubMed] [Google Scholar]
  122. Winkel BMF, Dalenberg MR, de Korne CM, Feijt C, Langenberg MCC, Pelgrom L, Ganesh MS, Yazdanbakhsh M, Smits HH, de Jong EC, Everts B, van Leeuwen FWB, Hokke CH, Roestenberg M. 2018. Early induction of human regulatory dermal antigen presenting cells by skin-penetrating Schistosoma mansoni cercariae. Frontiers in Immunology, 9, 2510. [CrossRef] [PubMed] [Google Scholar]
  123. Woellner-Santos D, Tahira AC, Malvezzi JVM, Mesel V, Morales-Vicente DA, Trentini MM, Marques-Neto LM, Matos IA, Kanno AI, Pereira ASA, Teixeira AAR, Giordano RJ, Leite LCC, Pereira CAB, DeMarco R, Amaral MS, Verjovski-Almeida S. 2024. Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques. NPJ Vaccines, 9(1), 5. [CrossRef] [PubMed] [Google Scholar]
  124. Wu H, Su Z, Barnie PA. 2020. The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targets. International Immunopharmacology, 78, 106111. [CrossRef] [PubMed] [Google Scholar]
  125. Wu X-J, Sabat G, Brown JF, Zhang M, Taft A, Peterson N, Harms A, Yoshino TP. 2009. Proteomic analysis of Schistosoma mansoni proteins released during in vitro miracidium-to-sporocyst transformation. Molecular and Biochemical Parasitology, 164(1), 32–44. [CrossRef] [PubMed] [Google Scholar]
  126. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature, 376(6541), 594–596. [CrossRef] [PubMed] [Google Scholar]
  127. Yan H, Dai Y, Zhang X, Zhang H, Xiao X, Fu J, Zou D, Yu A, Jiang T, Li XC, Zhao Z, Chen W. 2023. The transcription factor IRF4 determines the anti-tumor immunity of CD8+ T cells. iScience, 26(11), 108087. [CrossRef] [PubMed] [Google Scholar]
  128. Yan JB, Luo MM, Chen ZY, He BH. 2020. The Function and role of the Th17/Treg cell balance in inflammatory bowel disease. Journal Immunology Research, 2020, 8813558. [Google Scholar]
  129. Yin X, Chen S, Eisenbarth SC. 2021. Dendritic cell regulation of T helper cells. Annual Review of Immunology, 39, 759–790. [CrossRef] [PubMed] [Google Scholar]
  130. Yo JH, Barbour TD, Nicholls K. 2019. Management of refractory lupus nephritis: challenges and solutions, Open Access Rheumatology: Research and Reviews, 11, 179–188. [CrossRef] [Google Scholar]
  131. Yoshino TP, Brown M, Wu XJ, Jackson CJ, Ocadiz-Ruiz R, Chalmers IW, Kolb M, Hokke CH, Hoffmann KF. 2014. Excreted/secreted Schistosoma mansoni venom allergen-like 9 (SmVAL9) modulates host extracellular matrix remodelling gene expression. International Journal of Parasitology, 44(8), 551–563. [CrossRef] [Google Scholar]
  132. Yoshino TP, Wu XJ, Liu H, Gonzalez LA, Deelder AM, Hokke CH. 2012. Glycotope sharing between snail hemolymph and larval schistosomes: larval transformation products alter shared glycan patterns of plasma proteins, PLoS Neglected Tropical Diseases, 6(3), e1569. [CrossRef] [PubMed] [Google Scholar]
  133. Yu R, Zuo F, Ma H, Chen S. 2019. Exopolysaccharide-producing Bifidobacterium adolescentis strains with similar adhesion property induce differential regulation of inflammatory immune response in Treg/Th17 axis of dss-colitis mice. Nutrients, 11(4), 782. [CrossRef] [PubMed] [Google Scholar]
  134. Zheng B, Zhang J, Chen H, Nie H, Miller H, Gong Q, Liu C. 2020. T lymphocyte-mediated liver immunopathology of schistosomiasis. Frontiers in Immunology, 11, 61. [CrossRef] [PubMed] [Google Scholar]
  135. Zhu B, Luo F, Shen Y, Yang W, Sun C, Wang J, Li J, Mo X, Xu B, Zhang X, Li Y, Hu W. 2020. Schistosoma japonicum cathepsin B2 (SjCB2) facilitates parasite invasion through the skin. PLoS Neglected Tropical Diseases, 14(10), e0008810. [CrossRef] [PubMed] [Google Scholar]
  136. Zhu J. 2015. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine, 75(1), 14–24. [CrossRef] [PubMed] [Google Scholar]
  137. Zhu L, Hua F, Ding W, Ding K, Zhang Y, Xu C. 2020. The correlation between the Th17/Treg cell balance and bone health. Immunity and Ageing, 17, 30. [CrossRef] [Google Scholar]
  138. Zi C, He L, Yao H, Ren Y, He T, Gao Y. 2022. Changes of Th17 cells, regulatory T cells, Treg/Th17, IL-17 and IL-10 in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Endocrine, 76(2), 263–272. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.